Creegh Pharmaceuticals Inc.
Pittsburgh, PA
- UEI
- L6AZATV6ZKH3
- CAGE
- 8CE22
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 5801 Wilkins Ave, Pittsburgh, PA 15217, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Synergize a novel homologous recombination inhibitor with DNA damagingagents in tnbc - 15-20% of all breast cancers… | National Cancer Institute | $391,976 |
Quick answers
What is Creegh Pharmaceuticals Inc.'s UEI?
Creegh Pharmaceuticals Inc.'s Unique Entity ID (UEI) in SAM.gov is L6AZATV6ZKH3.
What is Creegh Pharmaceuticals Inc.'s CAGE code?
Creegh Pharmaceuticals Inc.'s CAGE code is 8CE22.
Where is Creegh Pharmaceuticals Inc. located?
Creegh Pharmaceuticals Inc.'s physical address in SAM.gov is 5801 Wilkins Ave, Pittsburgh, PA 15217, USA.
Is Creegh Pharmaceuticals Inc. registered in SAM.gov?
Yes. Creegh Pharmaceuticals Inc.'s SAM.gov registration is active through April 9, 2027.
What is Creegh Pharmaceuticals Inc.'s most recent federal award?
Creegh Pharmaceuticals Inc.'s most recent federal grant award is Synergize a novel homologous recombination inhibitor with DNA damagingagents in tnbc - 15-20% of all breast cancers… (R41CA281511), from National Cancer Institute, on September 20, 2023.
On GovTribe
See Creegh Pharmaceuticals Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors